Introduction
There are few cases of isolated splenic tuberculosis reported in the literature internationally, and nearly none from western medical centers. The incidence of tuberculosis has declined in the United States since the 1950s, with 11,585 reported cases in 2009, 21% of which were exclusively extrapulmonary.
Splenic tuberculosis occurs mostly as part of miliary tuberculosis in immunocompromised patients. Isolated splenic tuberculosis is extremely rare, particularly in the immunocompetent patient. Patients susceptible to acquiring splenic tuberculosis usually have one of the following risk factors: immunosuppression, preceding pyogenic infections, splenic abnormalities, prior trauma to the spleen, sickle cell disease and other hemopathies, and in the immunocompetent patient another body site infected by M. tuberculosis. In this report we present the case of a young immunocompetent male with no other significant past medical history with isolated splenic tuberculosis.
Presentation of case
A 27 year old African American male presented to the emergency department with epistaxis for three days. He had associated generalized weakness, anorexia, unintentional 50 lb weight loss, and night sweats. His history was significant for 10 years incarceration; he was released five months prior to this admission and his health subsequently deteriorated with regards to weight loss and fatigue.
Physical exam revealed a cachectic, afebrile man with a tender abdomen and hepatosplenomegaly. His blood work was remarkable for platelet count of 8000, AST 59, alkaline phosphatase 606 and LDH 388. HIV ELISA was negative. He was admitted with a working diagnosis of idiopathic thrombocytopenic purpura.
On his first hospital day, PPD was placed and was negative. He was started on IVIg at 0.5 mg/kg. Computed tomography (CT) imaging of abdomen and pelvis showed splenomegaly with diffuse heterogenous enhancement and innumerable lesions, as well as diffuse lymphadenopathy in the porta hepatis, splenic hilum, retroperitoneum and pelvis. Homogenous hepatomegaly without focal hypodensities was also noted (Fig. 1) . CT of the chest showed 1.9 cm left lung lower lobe nodule with irregular margins, bilateral hilar lymphadenopathy, and multiple enlarged mediastinal lymph nodes were present. Whole body PET scan was performed to evaluate for lymphoma and metastatic disease and showed splenomegaly with hypermetabolic FDG activity, with hypermetabolic lymphadenopathy in mediastinum, retroperitoneum, mesentery and pelvis.
Bone marrow biopsy was performed and revealed megakaryocytic hyperplasia. On day three of IVIg treatment he showed no major improvement and therapy with decadron initiated. On fifth hospital day, his platelet count was less than 5000 and he was subsequently given platelet transfusion and evaluated by surgery for splenectomy. On seventh hospital day, a repeat CT of the abdomen showed significant gastric varices and portal hypertension. Splenectomy was performed due to failure of medical management. The splenectomy was approached via laparotomy due to the preoperative evidence of gastric varices. Operative findings were significant for large hepatosplenomegaly and highly- was complicated by fungemia; he was treated and discharged home.
The weight of the spleen was 1430 grams and it measured 33 × 18 × 8 cm. On gross appearance, the surface of the spleen was irregularly nodular and brown (Fig. 2) . The entire spleen was replaced by caseating granulomas and necrotizing-type granulomatous inflammation (Figs. 3 and 4) . Mycobacterium tuberculosis bacteria were seen by AFB stain. Splenic hilar lymph nodes with non-caseating granulomas were also visualized.
Discussion
Tuberculosis of the spleen was first described in literature in 1846 by Coley referring to enlarged spleen secondary to tuberculosis with absent or limited involvement of other organs. 8 Approximately 15-20% of all cases of TB are extrapulmonary, 4 and of these, 3-11% are abdominal. 4, 10 As a corollary to the lack of isolated splenic tuberculosis in the United States, it is necessary to turn to international literature for guidelines for diagnosis and treatment of these patients.
Clinically, the most common symptoms that patients present with are fever (82.3%), fatigue and weight loss (44.12%), and splenomegaly (13.2-100%). 7, 11 Rarely, patients can be asymptomatic and their diagnosis is delayed. Pain is an uncommon symptom. 6 Other presentations include splenic rupture, 4 hypersplenism, portal hypertension with and without gastrointestinal bleed, 11 and fulminant form involving rapid progression of fever, cachexia, hemorrhage and sepsis. 11 Splenic tuberculosis patients can also present with hematologic abnormalities. Usually they are cytopenic, but cases of polycythemia have also been reported. 1 Diagnosis. PPD is often positive in these patients. However, this is unreliable in endemic countries, immunocompromised patients, and foreign-born patients who received BCG vaccine. 1 PCR has much higher sensitvity and specificity, and can identify organism to the species. 1, 6 Sonogram can help differentiate miliary tuberculosis, nodular, tuberculous abscess, calcific tuberculosis, and mixed type. 13 Tuberculomas can also be identified as multiple hypoechoic lesions, well-demarcated with posterior enhancement. When these are visualized, lymphoma, acute leukemia, angiomas, metastases, and fungal infections should also be ruled out. On computed tomography, tuberculomas appear as non-enhancing homogenous hypodensities and homogenous splenomegaly can also be appreciated. 11, 12 Fine needle aspiration cytology is a valuable too, with sensitivity of 88% and specificity of up to 100%. 10, 11 It should be considered whenever splenomegaly presents with fever of unknown origin. FNAC can also reveal caseating granulomas. 11, 13 Laparoscopy may be indicated when less invasive diagnostic methods have failed. 9, 11 Splenectomy should be a last resort for diagnosis.
Treatment. Antituberculous medications are the first line of treatment. 1, 4, 5, 7, 11, 13 Triple or quadruple therapy for at least 12 months is indicated. 4, 5, 13 Splenectomy is usually unnecessary as a mode of treatment, except for under particular conditions. 4, 11 These indications include failure of medical treatment, cytopenia or polycythemia, tuberculous splenomegaly with gastrointestinal bleeding secondary to portal hypertension, failure of percutaneous abscess drainage, and multiple splenic abscesses. Antituberculous therapy should also be initiated in patients status post splenectomy. Imaging studies such as ultrasound or computed tomography can be used to gauge the success of treatment. 11 MRI and PET scans are useful in determining the amount of activity in splenic lesions and differentiating active vs. fibrotic scars. 12 
Conclusion
Isolated splenic tuberculosis is rare and is usually associated with immunosuppression, though not exclusively. Usually there is another focus of infection. Splenectomy should be reserved for diagnostic uncertainty, cases refractory to medical treatment, and in specific conditions as mentioned above.
Key learning points
• Isolated splenic tuberculosis is such a rare entity, that only small case reports such as ours are found in the literature.
• We hope that our case highlights one of the many ways splenic tuberculosis in a patient that is immunocompetent may present.
• If one is found to have a patient with similar laboratory findings, signs and symptoms they will be able to place isolated splenic tuberculosis in their diagnostic differential.
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